Log In
BCIQ
Print this Print this
 

Fastic, Starlix, Starsis, nateglinide (YM026)

Also known as: A-4166

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionD-phenylalanine amino acid derivative
Molecular Target ATP-dependent potassium channel (KATP)
Mechanism of ActionATP-dependent potassium channel (KATP) blocker
Therapeutic ModalityPeptide
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsPrevent Type II diabetes; Treat Type II diabetes; Treat Type II diabetes in combination with thiazolidinedione
Regulatory Designation
PartnerAjinomoto Co. Inc.;
Astellas Pharma Inc.;
Daiichi Sankyo Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/12/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today